SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-191155
Filing Date
2021-06-15
Accepted
2021-06-15 16:10:58
Documents
5
Period of Report
2021-06-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d177137d8k.htm 8-K 20439
2 EX-3.1 d177137dex31.htm EX-3.1 24726
3 EX-3.2 d177137dex32.htm EX-3.2 120924
4 EX-99.1 d177137dex991.htm EX-99.1 5244
5 GRAPHIC g177137g0615132324322.jpg GRAPHIC 4257
  Complete submission text file 0001193125-21-191155.txt   178525
Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40475 | Film No.: 211018650
SIC: 2834 Pharmaceutical Preparations